ATXS Financials

Astria Therapeutics Inc - Financial statements & key metrics

Stock Price

$0.00

Market Cap

$382.06M

EPS

$-2.14

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-94.26M

EPS (Diluted)

$-1.68

Balance Sheet Highlights

Total Assets

$342.36M

Total Liabilities

$23.10M

Shareholders Equity

Cash & Equivalents

$59.82M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-81.21M

CapEx

Free Cash Flow

Profitability Metrics

Operating Margin

-4830.6%

ROE

-43.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ATXS revenue?

View ATXS's income statement for detailed revenue data.

Is ATXS profitable?

ATXS reported a loss of $94.26M in the most recent quarter.

What is ATXS market cap?

ATXS has a market capitalization of $382.06M, making it a small-cap stock.

Does ATXS have debt?

View ATXS's balance sheet for debt information.

What is ATXS cash flow?

Cash flow data is available in the full financial statements.